Ombitasvir/paritaprevir/ritonavir - AbbVie/Enanta Pharmaceuticals
At a glance
- Drug Originator Enanta Pharmaceuticals
- Drug Licenced by AbbVie
- Drug Class Amides; Anilides; Antiretrovirals; Antivirals; Aza compounds; Carbamates; Cyclopropanes; Phenanthridines; Pyrroles; Pyrrolidines; Small molecules; Sulfones; Thiazoles
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors; HIV protease inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 45
- NDAs 2
- International Patents 608
- Patent Applications 22
Table of Contents

Disclaimer